Related Experiment Video

Updated: May 2, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.6K

Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes

Essam M Abdelalim1, Amélie Bonnefond, Annelise Bennaceur-Griscelli

  • 1Qatar Biomedical Research Institute, Qatar Foundation, Education City, 5825, Doha, Qatar, emohamed@qf.org.qa.

Stem Cell Reviews and Reports
|March 1, 2014
PubMed

Insights

Pluripotent stem cells (PSCs), including induced PSCs (iPSCs), offer a promising avenue for diabetes research and treatment. Patient-specific iPSCs can differentiate into insulin-producing beta cells, aiding disease modeling and potential cell therapy.

Area of Science:

  • Biomedical Science
  • Stem Cell Biology
  • Endocrinology

Background:

  • Diabetes mellitus is a prevalent global disease with poorly understood pathogenesis and no definitive cure.
  • Pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced PSCs (iPSCs), show potential for diabetes research and therapy.
  • Generating patient-specific PSCs is crucial for in vitro disease modeling and personalized cell replacement strategies.

Purpose of the Study:

  • To review recent advancements in differentiating pancreatic beta cells from PSCs.
  • To discuss the challenges and potential of PSCs for clinical diabetes cell therapy.
  • To explore the utility of patient-specific PSCs in understanding diabetes pathophysiology.

Main Methods:

  • Review of current literature on PSC differentiation into pancreatic beta cells.
  • Analysis of iPSC technology for generating patient-specific cells.
  • Evaluation of challenges in clinical translation of PSC-based therapies.

Main Results:

  • iPSCs can be generated from diabetic patients and differentiated into insulin-secreting beta cells.
  • iPSC technology bypasses ethical concerns and immune rejection risks associated with ESCs.
  • Patient-specific iPSCs hold promise for both in vitro disease modeling and potential cell therapy.

Conclusions:

  • PSCs, particularly iPSCs, represent a significant advancement in diabetes research and therapeutic strategies.
  • Further research is needed to overcome challenges for the clinical application of PSC-derived beta cells.
  • Patient-specific iPSCs offer valuable insights into diabetes pathogenesis and personalized treatment approaches.

More Related Videos

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice06:53

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice

Published on: April 10, 2026

93
Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

7.3K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
25.8K